The effect of liver disease on urine caffeine metabolite ratios. Read more about The effect of liver disease on urine caffeine metabolite ratios.
Validation of urine caffeine metabolite ratios with use of stable isotope-labeled caffeine clearance. Read more about Validation of urine caffeine metabolite ratios with use of stable isotope-labeled caffeine clearance.
Sympathomimetic effects of paraxanthine and caffeine in humans. Read more about Sympathomimetic effects of paraxanthine and caffeine in humans.
Metabolism of nicotine to cotinine studied by a dual stable isotope method. Read more about Metabolism of nicotine to cotinine studied by a dual stable isotope method.
Divergent tolerance to metabolic and cardiovascular effects of nicotine in smokers with low and high levels of cigarette consumption. Read more about Divergent tolerance to metabolic and cardiovascular effects of nicotine in smokers with low and high levels of cigarette consumption.
In vivo and in vitro correlation of microsomal epoxide hydrolase inhibition by progabide. Read more about In vivo and in vitro correlation of microsomal epoxide hydrolase inhibition by progabide.
Altered patterns of drug metabolism in patients with acquired immunodeficiency syndrome. Read more about Altered patterns of drug metabolism in patients with acquired immunodeficiency syndrome.
